Is Nubeqa approved for Metastatic CRPC? - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

Is Nubeqa approved for Metastatic CRPC?

davebliz profile image
4 Replies

From my limited reading Nubeqa seems to be used for Metastatic HSPC, is it also used for metastatic CRPC? thanks.

Written by
davebliz profile image
davebliz
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Tall_Allen profile image
Tall_Allen

It is only approved for NON-metastatic CRPC.

davebliz profile image
davebliz in reply to Tall_Allen

Oh, so I had it totally wrong. Any idea if they have done any trials with it for metastatic, and if so, was it shown to be non-effective? thanks.

Tall_Allen profile image
Tall_Allen in reply to davebliz

Trials are ongoing

Leader4077 profile image
Leader4077

Last year on May 1, asked my MO to look into her starting me on Darolutamide. She said since my Firmagon shots were working so well reducing PSA(down to 0.16 from 40 .6 in just 6 months), I probably wouldn’t qualify for their “free” 2 month trial. She convinced me not to pursue it at the time. Went off Firmagon also for 5 months.......BIG MISTAKE....in 3 months PSA went up to 1.17, by 5 months it was up to 4.0........scans in mid December revealed 6 bone Mets with a PSAof 20.2. Diagnosis changed to Metastatic. Not eligible for Darolutamide.

Started Docetaxel in January and taking last infusion next week.........PSA has dropped with each infusion but have learned a hard lesson. Got a new MO in January, 2021.

Mike

You may also like...

nubeqa only for non metastatic?

I was just reading here that nubeqa is approved only for non metastatic castration resistant....

Olaparib Combo Improves PFS/Responses in Metastatic CRPC - from ASCO GU2024

com/view/olaparib-combo-improves-pfs-responses-in-metastatic-crpc

FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer

al-sought-for-darolutamide-plus-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer More...

ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC

com/view/onct-534-earns-fda-fast-track-designation-in-r-r-metastatic-crpc

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

approved-drugs/fda-approves-darolutamide-non-metastatic-castration-resistant-prostate-cancer